VLG look very cheap to me19 Aug 2021 09:50
VLG are forecast by Cenkos to make 4.6p adjusted EPS this year, rising to 6.21p EPS next year - against a 69p share price, and with hefty facilities to enable further large earnings-enhancing acquisitions.
Cenkos note that this could bring in £2m additional EBITDA in 2021, or if no acquisitions this year, then a further £3m EBITDA next year.
The key point here is that the core business is trading well and should pick up further, as highlighted by Cenkos:
"The core business, defined as the business excluding sales of Dentyl to the Chinese partner and HSG, is expected to report 9% growth in H1/21E, which we view as a strong result given the ongoing pandemic. While the impact of COVID continued into H1/21, the company is encouraged by indications of a post-pandemic recovery in UK retail, which we expect to support growth in this core business."
"At an adjusted level, we expect diluted EPS for FY21E to be 4.5p, up c19% versus our previous estimate of 3.8p. We forecast adjusted diluted EPS of 6.2p for FY22E, indicating growth of 37% YoY."
Management should have been much more open about the decline in the exceptional HSG and Dentyl China categories. But that doesn't offset the fact that the core business is building nicely and has the potential to grow much faster both organically and via acquisition.